Medical Supply Chain Security Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Mar 24, 2022)
Medical Supply Chain Security Act
This bill requires manufacturers of essential medical devices (i.e., those that are life supporting, life-sustaining, or intended for use for a debilitating disease or condition) to notify the Food and Drug Administration (FDA) if the device is discontinued or if there is any meaningful disruption to the device's manufacturing. The bill also authorizes the FDA to expedite review of such a device to mitigate or prevent a shortage.
The bill also requires the manufacturer of an essential medical device or drug to report annually to the FDA certain information, such as details about all locations of production and the sourcing of component parts or active pharmaceutical ingredients.
What just happenedMar 25, 2022
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseMar 24, 2022
- Mar 25, 2022Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 24, 2022IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Mar 24, 2022IntroReferralIntro-H
Introduced in House
- Mar 24, 2022IntroReferral1000
Introduced in House